Ann Clin Neurophysiol.  2020 Apr;22(1):8-12. 10.14253/acn.2020.22.1.8.

Insight into the prognostic factors ofchronic inflammatory demyelinatingpolyneuropathy

Affiliations
  • 1Department of Neurology, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea

Abstract

Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune-mediated neuropathy with heterogeneous features. Appropriate treatment will produce a favorable outcome, but a poor treatment response and severe disability have also been reported. The roles of the clinical phenotypes and electrophysiological features of CIDP as well as of autoantibodies against nodal and paranodal proteins have been highlighted previously due to their association with the treatment response and long-term prognosis. This review addresses the diverse factors associated with the prognosis of CIDP.

Keyword

Autoantibody; Chronic inflammatory demyelinating polyneuropathy; Clinical phenotype; Electrodiagnosis; Prognosis; Treatment
Full Text Links
  • ACN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr